A Dublin - based biotech firm has raised € ##50 m ( $ 19.2 m ) in a series A funding round to support its work in discovering and making use of bioactive peptides to assist in the treatment of diseases . insulin , whose CEO is former Nestlé executive Emmet ##z , has now raised a total of € 25 m since its launch in 2014 , including $ 3 m from the European fund for a project that explores using artificial intelligence ( AI ) to try to prevent diabetes . Bioactive peptides plays a role in managing the condition , and the AI technology used by Nuritas speeds up the process of identifying those which may help .
A Dublin-based biotech firm has raised €16m ($19.2m) in a series A funding round to support its work in discovering and making use of bioactive peptides to assist in the treatment of diseases. Nuritas, whose CEO is former Nestlé executive Emmet Browne, has now received a total of €25m since its launch in 2014, including $3m from the European Union for a project that explores using artificial intelligence (AI) to help to prevent diabetes. Bioactive peptides play a role in managing the condition, and the AI technology used by Nuritas speeds up the process of identifying those which may help.